Outset Medical (OM) Faces Delisting Threat Amidst Regulatory Woes and Investor Lawsuit – Hagens Berman
OM Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO, CA / ACCESSWIRE / October 17, 2024 / Outset Medical, Inc. (NASDAQ:OM) is facing a perilous situation as it grapples with a potential delisting from the Nasdaq and a class-action lawsuit alleging investor fraud. In a notice received on September 23, 2024, the company […]